{
    "clinical_study": {
        "@rank": "95668", 
        "acronym": "MiD", 
        "arm_group": {
            "arm_group_label": "REVEAL XT Implantable cardiac monitor", 
            "arm_group_type": "Other", 
            "description": "Monitoring of cardiac arrhythmic events and the relationship between such events and the characteristics."
        }, 
        "brief_summary": {
            "textblock": "The primary objective of this study is to estimate the proportion of hemodialysis patients\n      experiencing clinically significant cardiac arrhythmias over a 6-month period using\n      continuous cardiac monitoring with an implanted Medtronic Reveal XT device."
        }, 
        "brief_title": "Study the Characteristics of Cardiac Related Events in Hemodialysis Patients", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "End Stage Renal Disease", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  21 years of age or older and is willing to be implanted with the Reveal XT\n\n          -  Currently on hemodialysis at least three times per week OR has an estimated\n             glomerular filtration rate (eGFR) of < 15 mL/min/1.73m^2 and is expected to begin\n             hemodialysis within 2 months.\n\n          -  Subject is willing and able to comply with the protocol\n\n        Exclusion Criteria:\n\n          -  Currently enrolled in an interventional study that may interfere with the Monitoring\n             in Dialysis protocol\n\n          -  Not suitable for Reveal XT implantation\n\n          -  Has an existing hemodialysis catheter that may interfere with the Reveal XT\n             implantation site\n\n          -  Has a recent infection\n\n          -  Is currently on hemodialysis with a hemoglobin < 10 g/dL\n\n          -  Has end-stage liver failure or has had thoracic surgery within the past 6 months\n\n          -  Has an existing pacemaker, implantable cardioverter-defibrillator (ICD) or cardiac\n             resynchronization device\n\n          -  Is scheduled for renal transplantation or will likely be transplanted within 6 months\n\n          -  Is currently on home hemodialysis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01779856", 
            "org_study_id": "G120171"
        }, 
        "intervention": {
            "arm_group_label": "REVEAL XT Implantable cardiac monitor", 
            "intervention_name": "REVEAL XT Implantable cardiac monitor", 
            "intervention_type": "Device", 
            "other_name": "Reveal XT"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "End Stage Renal Disease, Hemodialysis, Arrhythmia, Reveal XT", 
        "lastchanged_date": "April 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Augusta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30901"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02120"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45267"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chattanooga", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37408"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chennai", 
                        "country": "India", 
                        "zip": "600006"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gurgaon", 
                        "country": "India", 
                        "zip": "122001"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hyderabad", 
                        "country": "India", 
                        "zip": "500034"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Delhi", 
                        "country": "India", 
                        "zip": "110070"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Delhi", 
                        "country": "India", 
                        "zip": "110076"
                    }
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "India"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Monitoring in Dialysis", 
        "overall_contact": {
            "email": "rs.dialysis.study@medtronic.com", 
            "last_name": "Sarah Mische"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Events defined as clinically significant for the objective include: episodes of ventricular tachycardia (VT) greater than or equal to 130 beats per minute (BPM), episodes of bradycardia indicated by a recorded heart rate less than or equal to 40 BPM, instances of asystole lasting at least three seconds, or any symptomatic event, indicated by patient use of the Reveal XT Patient Assistant, where review of the stored ECG shows an arrhythmia considered clinically significant in the judgement of the study site cardiologist.", 
            "measure": "Estimate the proportion of hemodialysis patients who experience clinically significant cardiac arrhythmias using continuous cardiac monitoring over a 6-month period with an implanted Medtronic Reveal XT device.", 
            "safety_issue": "No", 
            "time_frame": "6 months of dialysis data following Reveal XT implant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01779856"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Collect the number of device and procedure related adverse events (AEs).", 
                "safety_issue": "No", 
                "time_frame": "6 months of dialysis data following Reveal XT implant"
            }, 
            {
                "measure": "Correlate clinically significant arrhythmias (as defined above) to hemodialysis session parameters and health-related events associated with ESRD.", 
                "safety_issue": "No", 
                "time_frame": "6 months of dialysis data following Reveal XT implant"
            }
        ], 
        "source": "Medtronic Corporate Technologies and New Ventures", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Corporate Technologies and New Ventures", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}